Conversely, Miranda et al. observed that MDM4 protein levels were often elevated in breast cancers expressing mutant p53, and that MDM4 knockdown inhibited the growth of mutant p53 cells both in vitro and in vivo [16]. This evidence concerns the gene TP53 and breast cancer.